Advertisement

Immunogenetics

, Volume 70, Issue 10, pp 671–680 | Cite as

Analysis of the affinity of influenza A virus protein epitopes for swine MHC I by a modified in vitro refolding method indicated cross-reactivity between swine and human MHC I specificities

  • Shuhua Fan
  • Yongli Wang
  • Xian Wang
  • Li Huang
  • Yunxia Zhang
  • Xiaomeng Liu
  • Wenshuai Zhu
Original Article
  • 92 Downloads

Abstract

In vitro refolding assays can be used to investigate the affinity and stability of the binding of epitope peptides to major histocompatibility complex (MHC) class I molecules, which are key factors in the presentation of peptides to cytotoxic T lymphocytes (CTLs). The recognition of peptide epitopes by CTLs is crucial for protection against influenza A virus (IAV) infection. The peptide-binding motif of the swine SLA-3*hs0202 molecule has been previously reported and partly overlaps with the binding motif of the most abundant human MHC allele, HLA-A*0201. In this study, we screened all the protein sequences of the swine-origin epidemic IAV strain A/Beijing/01/2009 (H1N1), and a total of 73 9-mer epitope peptides were predicted to fit the consensus motif of the swine SLA-3*hs0202 or HLA-A*0201 molecule. Then, 14 peptides were selected, and their affinities to SLA-3*hs0202 were tested by a modified in vitro refolding assay. Our results show that ten epitopes could tolerate gel filtration, indicating that these epitopes formed stable or partly stable complexes with SLA-3*hs0202. Eight out of the ten epitopes have been previously reported as HLA-A2-restricted epitopes, which implied cross-reactivity between swine and human MHC I specificities. Furthermore, the modified mini-system refolding method could be applied for the screening of peptides because the refolding efficiency remained almost unchanged with the positive peptide (HA-KMN9) subjected to size-exclusion chromatography and Resource Q anion-exchange chromatography. The results presented here provide new insight into the development of epitope-based vaccines to control IAV and increase our understanding of swine molecular immunology.

Keywords

MHC I Influenza A virus Peptide epitope CTL immunity 

Notes

Funding information

This study was funded by the State Key Program of the National Natural Science Foundation of China (Grant No. 31702232), by the Zhoukou Normal University for doctoral researchers on scientific research and innovation (Grant No. ZKNUC2016029), and by the Youth Teacher Scientific Research and Innovation Program of Zhoukou Normal University (Grant No. ZKNUB2201710).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Supplementary material

251_2018_1070_MOESM1_ESM.docx (38 kb)
Online Resource 1 Potential 9-mer epitope peptides selected from the IAV genome by an in silico prediction method based on the HLA-A*0201 and SLA-3*hs0202 motifs. IAV type, 2009 pandemic H1N1 (A/Beijing/01/2009). Estimated binding affinity to SLA-3*hs0202 and HLA-A*0201 was calculated using the website http://www.cbs.dtu.dk/services/NetMHCpan-2.8/ (Hoof et al. 2009). A total of 73 nonapeptides were predicted from IAV proteins based on the SLA-3*hs0202 and HLA-A*0201 binding motifs using the NetMHCpan 2.8 server, and the estimated binding affinities to SLA I are represented as IC50 values. The peptides were selected with theoretical IC50 values ranging from 3 to 29047.6 nM, and IC50 values are inversely proportional to binding affinities. (DOCX 37 kb)

References

  1. Altfeld MA, Livingston B, Reshamwala N, Nguyen PT, Addo MM, Shea A, Newman M, Fikes J, Sidney J, Wentworth P, Chesnut R, Eldridge RL, Rosenberg ES, Robbins GK, Brander C, Sax PE, Boswell S, Flynn T, Buchbinder S, Goulder PJR, Walker BD, Sette A, Kalams SA (2001) Identification of novel HLA-A2-restricted human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte epitopes predicted by the HLA-A2 supertype peptide-binding motif. J Virol 75:1301–1311CrossRefGoogle Scholar
  2. Assarsson E, Bui HH, Sidney J, Zhang Q, Glenn J, Oseroff C, Mbawuike IN, Alexander J, Newman MJ, Grey H, Sette A (2008) Immunomic analysis of the repertoire of T-cell specificities for influenza A virus in humans. J Virol 82:12241–12251CrossRefGoogle Scholar
  3. Choo JA, Liu J, Toh X et al (2014) The immunodominant influenza A virus M158-66 CTL epitope exhibits degenerate class I MHC restriction in humans. J Virol 88:10613–10623CrossRefGoogle Scholar
  4. Di Mario G, Garulli B, Sciaraffia E et al (2016) A heat-inactivated H7N3 vaccine induces cross-reactive cellular immunity in HLA-A2.1 transgenic mice. Virol J 13:56CrossRefGoogle Scholar
  5. Douat-Casassus C, Borbulevych O, Tarbe M et al (2010) Crystal structures of HLA-A*0201 complexed with Melan-A/MART-1(26(27L)-35) peptidomimetics reveal conformational heterogeneity and highlight degeneracy of T cell recognition. J Med Chem 53:7061–7066CrossRefGoogle Scholar
  6. Ducatez MF, Hause B, Stigger-Rosser E, Darnell D, Corzo C, Juleen K, Simonson R, Brockwell-Staats C, Rubrum A, Wang D, Webb A, Crumpton JC, Lowe J, Gramer M, Webby RJ (2011) Multiple reassortment between pandemic (H1N1) 2009 and endemic influenza viruses in pigs, United States. Emerg Infect Dis 17:1624–1629CrossRefGoogle Scholar
  7. Falk K, Rotzschke O, Stevanovic S et al (1991) Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290–296CrossRefGoogle Scholar
  8. Fan S, Wang Y, Wang S, Wang X, Wu Y, Li Z, Zhang N, Xia C (2018) Polymorphism and peptide-binding specificities of porcine major histocompatibility complex (MHC) class I molecules. Mol Immunol 93:236–245CrossRefGoogle Scholar
  9. Fan S, Wu Y, Wang S, Wang Z, Jiang B, Liu Y, Liang R, Zhou W, Zhang N, Xia C (2016) Structural and biochemical analyses of swine major histocompatibility complex class I complexes and prediction of the epitope map of important influenza A virus strains. J Virol 90:6625–6641CrossRefGoogle Scholar
  10. Garboczi DN, Hung DT, Wiley DC (1992) HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc Natl Acad Sci U S A 89:3429–3433CrossRefGoogle Scholar
  11. Gianfrani C, Oseroff C, Sidney J, Chesnut RW, Sette A (2000) Human memory CTL response specific for influenza A virus is broad and multispecific. Hum Immunol 61:438–452CrossRefGoogle Scholar
  12. Grant EJ, Josephs TM, Valkenburg SA, Wooldridge L, Hellard M, Rossjohn J, Bharadwaj M, Kedzierska K, Gras S (2016) Lack of heterologous cross-reactivity toward HLA-A*02:01 restricted viral epitopes is underpinned by distinct alphabetaT cell receptor signatures. J Biol Chem 291:24335–24351CrossRefGoogle Scholar
  13. Harndahl M, Justesen S, Lamberth K et al (2009) Peptide binding to HLA class I molecules: homogenous, high-throughput screening, and affinity assays. J Biomol Screen 14:173–80CrossRefGoogle Scholar
  14. Hillaire ML, Vogelzang-van Trierum SE, Kreijtz JH et al (2013) Human T-cells directed to seasonal influenza A virus cross-react with 2009 pandemic influenza A (H1N1) and swine-origin triple-reassortant H3N2 influenza viruses. J Gen Virol 94:583–592CrossRefGoogle Scholar
  15. Hirohashi Y, Torigoe T, Maeda A, Nabeta Y, Kamiguchi K, Sato T, Yoda J, Ikeda H, Hirata K, Yamanaka N, Sato N (2002) An HLA-A24-restricted cytotoxic T lymphocyte epitope of a tumor-associated protein, survivin. Clin Cancer Res 8:1731–1739PubMedGoogle Scholar
  16. Hoof I, Peters B, Sidney J, Pedersen LE, Sette A, Lund O, Buus S, Nielsen M (2009) NetMHCpan, a method for MHC class I binding prediction beyond humans. Immunogenetics 61:1–13CrossRefGoogle Scholar
  17. Hoppes R, Oostvogels R, Luimstra JJ, Wals K, Toebes M, Bies L, Ekkebus R, Rijal P, Celie PHN, Huang JH, Emmelot ME, Spaapen RM, Lokhorst H, Schumacher TNM, Mutis T, Rodenko B, Ovaa H (2014) Altered peptide ligands revisited: vaccine design through chemically modified HLA-A2-restricted T cell epitopes. J Immunol 193:4803–4813CrossRefGoogle Scholar
  18. Ishizuka J, Grebe K, Shenderov E, Peters B, Chen Q, Peng Y, Wang L, Dong T, Pasquetto V, Oseroff C, Sidney J, Hickman H, Cerundolo V, Sette A, Bennink JR, McMichael A, Yewdell JW (2009) Quantitating T cell cross-reactivity for unrelated peptide antigens. J Immunol 183:4337–4345CrossRefGoogle Scholar
  19. Ito T, Couceiro JN, Kelm S, Baum LG, Krauss S, Castrucci MR, Donatelli I, Kida H, Paulson JC, Webster RG, Kawaoka Y (1998) Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol 72:7367–7373PubMedPubMedCentralGoogle Scholar
  20. Keskin DB, Reinhold BB, Zhang GL, Ivanov AR, Karger BL, Reinherz EL (2015) Physical detection of influenza A epitopes identifies a stealth subset on human lung epithelium evading natural CD8 immunity. Proc Natl Acad Sci U S A 112:2151–2156CrossRefGoogle Scholar
  21. Langley WA, Bradley KC, Li ZN, Talekar GR, Galloway SE, Steinhauer DA (2010) The effects of preexisting immunity to influenza on responses to influenza vectors in mice. Vaccine 28:6305–6313CrossRefGoogle Scholar
  22. Lee JS, Chowdhury MY, Moon HJ et al (2013) The highly conserved HA2protein of the influenza A virus induces a cross protective immune response. J Virol Methods 194:280–88CrossRefGoogle Scholar
  23. Lee LY, Ha do LA, Simmons C et al (2008) Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest 118:3478–3490PubMedPubMedCentralGoogle Scholar
  24. Liu WJ, Tan S, Zhao M, Quan C, Bi Y, Wu Y, Zhang S, Zhang H, Xiao H, Qi J, Yan J, Liu W, Yu H, Shu Y, Wu G, Gao GF (2016) Cross-immunity against avian influenza A(H7N9) virus in the healthy population is affected by antigenicity-dependent substitutions. J Infect Dis 214:1937–1946CrossRefGoogle Scholar
  25. Liu J, Wu B, Zhang S, Tan S, Sun Y, Chen Z, Qin Y, Sun M, Shi G, Wu Y, Sun M, Liu N, Ning K, Ma Y, Gao B, Yan J, Zhu F, Wang H, Gao GF (2013) Conserved epitopes dominate cross-CD8+ T-cell responses against influenza A H1N1 virus among Asian populations. Eur J Immunol 43:2055–2069CrossRefGoogle Scholar
  26. Macdonald IK, Harkiolaki M, Hunt L, Connelley T, Carroll AV, MacHugh ND, Graham SP, Jones EY, Morrison WI, Flower DR, Ellis SA (2010) MHC class I bound to an immunodominant Theileria parva epitope demonstrates unconventional presentation to T cell receptors. PLoS Pathog 6:e1001149CrossRefGoogle Scholar
  27. Madden DR (1995) The three-dimensional structure of peptide-MHC complexes. Annu Rev Immunol 13:587–622CrossRefGoogle Scholar
  28. Mohammed F, Cobbold M, Zarling AL, Salim M, Barrett-Wilt GA, Shabanowitz J, Hunt DF, Engelhard VH, Willcox BE (2008) Phosphorylation-dependent interaction between antigenic peptides and MHC class I: a molecular basis for the presentation of transformed self. Nat Immunol 9:1236–1243CrossRefGoogle Scholar
  29. Naffakh N, van der Werf S (2009) April 2009: an outbreak of swine-origin influenza A(H1N1) virus with evidence for human-to-human transmission. Microbes Infect 11:725–728CrossRefGoogle Scholar
  30. Nelson MI, Stratton J, Killian ML, Janas-Martindale A, Vincent AL (2015) Continual reintroduction of human pandemic H1N1 influenza A viruses into swine in the United States, 2009 to 2014. J Virol 89:6218–6226CrossRefGoogle Scholar
  31. Park MS, Park SY, Miller KR, Collins EJ, Lee HY (2013) Accurate structure prediction of peptide-MHC complexes for identifying highly immunogenic antigens. Mol Immunol 56:81–90CrossRefGoogle Scholar
  32. Rosa DS, Ribeiro SP, Fonseca SG, Almeida RR, Santana VC, Apostólico JS, Kalil J, Cunha-Neto E (2015) Multiple approaches for increasing the immunogenicity of an epitope-based anti-HIV vaccine. AIDS Res Hum Retrovir 31:1077–1088CrossRefGoogle Scholar
  33. Smith GJ, Vijaykrishna D, Bahl J et al (2009) Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic. Nature 459:1122–1125CrossRefGoogle Scholar
  34. Smith TP, Rohrer GA, Alexander LJ, Troyer DL, Kirby-Dobbels KR, Janzen MA, Cornwell DL, Louis CF, Schook LB, Beattie CW (1995) Directed integration of the physical and genetic linkage maps of swine chromosome 7 reveals that the SLA spans the centromere. Genome Res 5:259–271CrossRefGoogle Scholar
  35. Sridhar S, Begom S, Bermingham A, Ziegler T, Roberts KL, Barclay WS, Openshaw P, Lalvani A (2012) Predominance of heterosubtypic IFN-gamma-only-secreting effector memory T cells in pandemic H1N1 naive adults. Eur J Immunol 42:2913–2924CrossRefGoogle Scholar
  36. Sun B, Li X, Wang Z, Xia C (2013) Complex assembly, crystallization and preliminary X-ray crystallographic analysis of the chicken MHC class I molecule BF2*1501. Acta Crystallogr Sect F Struct Biol Cryst Commun 69:122–125CrossRefGoogle Scholar
  37. Tan PT, Khan AM, August JT (2011) Highly conserved influenza A sequences as T cell epitopes-based vaccine targets to address the viral variability. Hum Vaccin 7:402–409CrossRefGoogle Scholar
  38. Wang TT, Tan GS, Hai R, Pica N, Ngai L, Ekiert DC, Wilson IA, Garcia-Sastre A, Moran TM, Palese P (2010) Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes. Proc Natl Acad Sci U S A 107:18979–18984CrossRefGoogle Scholar
  39. Wu KW, Chien CY, Li SW, King CC, Chang CH (2012) Highly conserved influenza A virus epitope sequences as candidates of H3N2 flu vaccine targets. Genomics 100:102–109CrossRefGoogle Scholar
  40. Yusuf M, Konc J, Sy Bing C et al (2013) Structurally Conserved Binding Sites of Hemagglutinin as Targets for Influenza Drug and Vaccine Development. J Chem Inf Model 53:2423–36CrossRefGoogle Scholar
  41. Zanker D, Waithman J, Yewdell JW, Chen W (2013) Mixed proteasomes function to increase viral peptide diversity and broaden antiviral CD8+ T cell responses. J Immunol 191:52–59CrossRefGoogle Scholar
  42. Zhang N, Qi J, Feng S, Gao F, Liu J, Pan X, Chen R, Li Q, Chen Z, Li X, Xia C, Gao GF (2011) Crystal structure of swine major histocompatibility complex class I SLA-1 0401 and identification of 2009 pandemic swine-origin influenza A H1N1 virus cytotoxic T lymphocyte epitope peptides. J Virol 85:11709–11724CrossRefGoogle Scholar
  43. Zhou M, Xu Y, Lou Z, Cole DK, Li X, Liu Y, Tien P, Rao Z, Gao GF (2004) Complex assembly, crystallization and preliminary X-ray crystallographic studies of MHC H-2Kd complexed with an HBV-core nonapeptide. Acta Crystallogr D Biol Crystallogr 60:1473–1475CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.College of Life Science and AgronomyZhoukou Normal UniversityZhoukouPeople’s Republic of China
  2. 2.Institute of Neuroscience and Translational MedicineZhoukou Normal UniversityZhoukouPeople’s Republic of China

Personalised recommendations